Wire Stories

Dr. Reddy’s Laboratories announces the launch of Abiraterone Acetate Tablets USP, 250 mg in the U.S. Market

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together…

6 years ago

Global Kiosk Market Growth, Trends and Forecasts 2020-2025 – Growing Number of ATMs & Kiosk Across Asia-Pacific – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Kiosk Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The…

6 years ago

Clover Biopharmaceuticals Initiates Phase 1 Clinical Trial for COVID-19 Vaccine Candidate

150 healthy adult and elderly participants expected to be enrolled in Phase 1 study COVID-19 vaccine candidate to be evaluated…

6 years ago

TOKYO--(BUSINESS WIRE)--MEDIROM, which operates over 300 salons nationwide under Re.Ra.Ku brands and others (Head office: Tokyo, Japan), is pleased to…

6 years ago

After COVID-19: the University of Nottingham Ningbo China Experience

NINGBO, China--(BUSINESS WIRE)--It became clear that China faced a public health emergency after almost all our students and many faculty…

6 years ago

CEO of Petronas speaks with IHS Markit Vice Chairman Daniel Yergin for the latest CERAWeek Conversations – available at www.ceraweek.com/conversations…

6 years ago

Rio Tinto announces details of board-led heritage process review

MELBOURNE, Australia--(BUSINESS WIRE)--Rio Tinto has launched a board-led review of its heritage management processes within Iron Ore following the events…

6 years ago

Altavair Expands in Asia with New Executive Appointment

LONDON & SINGAPORE--(BUSINESS WIRE)--Altavair Limited (“Altavair”), a UK based commercial aviation servicer, announced today the hiring of Beng Yip as…

6 years ago

AMTD International Inc. Announces Appointment of Independent Director

HONG KONG--(BUSINESS WIRE)--AMTD International Inc. (“AMTD International” or “the Company”) (NYSE: HKIB; SGX: HKB), a subsidiary of AMTD Group Company…

6 years ago

Terns Pharmaceuticals Initiates the LIFT Study, a Phase 2a Clinical Trial of TERN-101 for the Treatment of NASH

-LIFT study to assess safety and efficacy of farnesoid X receptor (FXR) agonist TERN-101 in fatty liver disease patients as…

6 years ago